The following table provides an overview of the latest patents of Fred Hutchinson Cancer Center that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3688157Apr 27, 2022High Efficiency Targeted In Situ Genome-Wide Profiling1
EP3636778Jan 12, 2022Agents For Use In Treating Facioscapulohumeral Dystrophy (Fshd)2
EP3363901Dec 30, 2020Compositions And Methods For Accurately Identifying Mutations3
EP2689010Nov 18, 2020Method And Compositions For Cellular Immunotherapy1
EP2884999Nov 4, 2020Method And Compositions For Cellular Immunotherapy1
EP2814959Jan 17, 2018Compositions And Methods For Accurately Identifying Mutations1